Article: Targeted Genetics Expands Manufacturing Agreement With GenVec.

Targeted Genetics Corporation today announced that it has expanded its contract manufacturing agreement with GenVec, Inc. . As a result of successful contract manufacturing feasibility studies conducted by Targeted Genetics, the Company will manufacture clinical grade material to support late-stage clinical trials for GenVec's oncology product candidate, TNFerade(TM). Financial terms of the agreement were not disclosed.

"We are pleased to expand our contract manufacturing agreement with GenVec. In successfully completing these feasibility studies, we continue to demonstrate our strength and expertise in the area of manufacturing," said H. Stewart Parker, ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!